Abstract
In an attempt to probe the effect of β-endorphin on insulin resistance, we used Wistar rats that were fed fructose-rich chow to induce insulin resistance. Insulin action on glucose disposal rate (GDR) was measured using the hyperinsulinemic euglycemic clamp technique, in which glucose (variable), insulin (40 mU/kg/min), and β-endorphin (6 ng/kg/min) or vehicle were initiated simultaneously and continued for 120 min. A marked reduction in insulin-stimulated GDR was observed in fructose-fed rats compared to normal control rats. Infusion of β-endorphin reversed the value of GDR, which was inhibited by naloxone and naloxonazine each at doses sufficient to block opioid µ-receptors. Opioidµ-receptors may therefore be activated by β-endorphin to improve insulin resistance. Next, soleus muscle was isolated to investigate the effect of β-endorphin on insulin signals. Insulin resistance in rats induced by excess fructose was associated with the impaired insulin receptor (IR), tyrosine autophosphorylation, and insulin receptor substrate (IRS)-1 protein content in addition to the significant decrease in IRS-1 tyrosine phosphorylation in soleus muscle. This impaired glucose transportation was also due to signaling defects that included an attenuated p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3-kinase) and Akt serine phosphorylation. However, IR protein levels were not markedly changed in rats with insulin resistance. β-endorphin infusion reversed the fructose-induced decrement in the insulin-signaling cascade with increased GDR. Apart from IR protein levels, infusion of β-endorphin reversed the decrease in protein expression for the IRS-1, p85 regulatory subunit of PI3-kinase, and Akt serine phosphorylation in soleus muscle in fructose-fed rats. The decrease in insulin-stimulated protein expression of glucose transporter subtype 4 (GLUT 4) in fructose-fed rats returned to near-normal levels after β-endorphin infusion. Infusion of β-endorphin may improve insulin resistance by modulating the insulin-signaling pathway to reverse insulin responsiveness.
Key words
Akt · β-Endorphin · Glucose transporter subtype 4 · Insulin receptor · Insulin receptor substrate-1 · Phosphatidylinositol 3-kinase
References
-
1
Chevlen E.
Opioids: a review.
Curr Pain Headache Rep.
2003;
7
15-23
-
2
Yaksh T L.
Pharmacology and mechanisms of opioid analgesic activity.
Acta anaesthesiol Scand.
1997;
41
94-111
-
3
Smith E M.
Opioid peptides in immune cells.
Adv Exp Med Biol.
2003;
521
51-68
-
4
Curry D L, Li C H.
Stimulation of insulin secretion by beta-endorphin (1-27 and 1-31).
Life Sci.
1987;
40
2053-2058
-
5
Locatelli A, Spotti D, Caviezel F.
The regulation of insulin and glucagon secretion by opiates: a study with naloxone in healthy humans.
Acta Diabetol.
1985;
22
25-31
-
6
Khawaja X Z, Green I C, Thorpe J R, Titheradge M A.
The occurrence and receptor specificity of endogenous opioid peptides with pancreas and liver of the rat. Comparison with brain.
Biochem J.
1990;
267
233-240
-
7
Cheng J T, Liu I M, Tzeng T F, Tsai C C, Lai T Y.
Plasma glucose lowering effect of β-endorphin in streptozotocin-induced diabetic rats.
Horm Meta Res.
2002;
34
570-576
-
8
Cheng J T, Liu I M, Hsu C F.
Rapid induction of insulin resistance in opioid mu-receptor knock-out mice.
Neurosci lett.
2003;
339
139-142
-
9
Kruszynska Y T, Olefsky J M.
Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus.
J Invest Med.
1996;
44
413-428
-
10
DeFronzo R A.
Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.
Diabetologia.
1992;
35
389-397
-
11
Shulman G I.
Cellular mechanisms of insulin resistance.
J Clin Invest.
2000;
106
171-176
-
12
Higashiura K, Ura N, Takada T, Li Y, Torii T, Togashi N, Takada M, Takizawa H, Shimamoto K.
The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.
Am J Hypertens.
2000;
13
290-297
-
13
Lambert K, Py G, Robert E, Mercier J.
Does high-sucrose diet alter skeletal muscle and liver mitochondrial respiration?.
Horm Metab Res.
2003;
35
546-550
-
14
Steele R.
Influence of glucose loading and injected insulin on hepatic glucose output.
Ann N Y Acad Sci.
1959;
82
420-430
-
15
Bessesen D H.
The role of carbohydrates in insulin resistance.
J Nutr.
2001;
131
S2782-S 2786
-
16
James D E, Jenkins A B, Kraegen E W.
Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats.
Am J Physiol.
1985;
248
E567-E574
-
17
Kurokawa K, Oka Y.
Insulin resistance and glucose transporter.
Nippon Rinsho.
2000;
58
310-314
-
18
King P A, Horton E D, Hirshman M F, Horton E S.
Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation.
J Clin Invest.
1992;
90
1568-1575
-
19
Anai M, Funaki M, Ogihara T, Kanda A, Onishi Y, Sakoda H, Inukai K, Nawano M, Fukushima Y, Yazaki Y, Kikuchi M, Oka Y, Asano T.
Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
Diabetes.
1999;
48
158-169
-
20
Jiang Z Y, Lin Y W, Clemont A, Feener E P, Hein K D, Igarashi M, Yamauchi T, White M F, King G L.
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.
J Clin Invest.
1999;
104
447-457
-
21
White M F.
The insulin signalling system and the IRS proteins.
Diabetologia.
1997;
40
S2-S17
-
22
Kitamura T, Ogawa W, Sakaue H, Hino Y, Kuroda S, Takata M, Matsumoto M, Maeda T, Konishi H, Kikkawa U, Kasuga M.
Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport.
Mol Cell Biol.
1998;
18
3708-3717
-
23
Klippel A, Kavanaugh W M, Pot D, Williams L T.
A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain.
Mol Cell Biol.
1997;
17
338-344
-
24
Lima M H, Ueno M, Thirone A C, Rocha E M, Carvalho C R, Saad M J.
Regulation of IRS-1/SHP2 interaction and AKT phosphorylation in animal models of insulin resistance.
Endocrine.
2002;
18
1-12
-
25
Carvalho E, Rondinone C, Smith U.
Insulin resistance in fat cells from obese Zucker rats - evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4.
Mol Cell Biol.
2000;
206
7-16
-
26
Cusi K, Maezono K, Osman A, Pendergrass M, Patti M E, Pratipanawatr T, DeFronzo R A, Kahn C R, Mandarino L J.
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.
J Clin Invest.
2000;
105
311-320
-
27
Goldstein A.
Binding selectivity profiles for ligands of multiple receptor types: focus on opioid receptors.
Trends Pharmacol Sci.
1987;
8
456-459
-
28
Ishizuka T, Cooper D R, Hernandez H, Buckley D, Standaert M, Farese R V.
Effects of insulin on diacylglycerol-protein kinase C signaling in rat diaphragm and soleus muscles and relationship to glucose transport.
Diabetes.
1990;
39
181-190
-
29
Van Epps-Fung M, Gupta K, Hardy R W, Wells A.
A role for phospholipase C activity in GLUT4-Mediated glucose transport.
Endocrinology.
1997;
138
5170-5175
-
30
Narita M, Ohnishi O, Nemoto M, Aoki T, Suzuki T.
The involvement of phosphoinositide 3-kinase (PI3-Kinase) and phospholipase C gamma (PLC gamma) pathway in the morphine-induced supraspinal antinociception in the mouse.
Nihon Shinkei Seishin Yakurigaku Zasshi.
2001;
21
7-14
-
31
Freye E, Latasch L.
Development of opioid tolerance - molecular mechanisms and clinical consequences.
Anasthesiol Intensivmed Notfallmed Schmerzther.
2003;
38
14-26
-
32
Liu I M, Liou S S, Chen W C, Chen P F, Cheng J T.
Signals in the activation of opioid µ-receptors by loperamide to enhance glucose uptake into cultured C2C12 cells.
Horm Metab Res.
2004;
36
210-214
-
33
Bandyopadhyay G, Standaert ML, Kikkawa U, Ono Y, Moscat J, Farese RV.
Effects of transiently expressed atypical (zeta, lambda), conventional (alpha, beta) and novel (delta, epsilon) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-zeta and C-lambda.
Biochem J.
1999;
337
461-470
-
34
Vollenweider P, Menard B, Nicod P.
Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3′ kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance.
Diabetes.
2002;
51
1052-1059
-
35
Ravichandran L V, Esposito D L, Chen J, Quon M J.
Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin.
J Biol Chem.
2001;
276
3543-3549
-
36
Liu I M, Niu C S, Chi T C, Kuo D H, Cheng J T.
Investigations of the mechanism of the reduction in plasma glucose by cold-stress in streptozotocin-induced diabetic rats.
Neurosci.
1999;
92
1137-1142
Prof. J.-T. Cheng
Department of Pharmacology, College of Medicine
National Cheng Kung University · Taiwan City · Taiwan 70101 · R.O.C.
Telefon: +886 (6) 237-2706
Fax: +886 (6) 238-6548 ·
eMail: jtcheng@mail.ncku.edu.tw